Effects of Free Fatty Acids on Insulin Sensitivity and Hemodynamics ...

14 downloads 180315 Views 163KB Size Report
in insulin-mediated glucose disposal were all inhibited. In contrast, the rise in blood pressure was increased about 2-fold (control plus 6 mm Hg vs. lipid plus 13 ...
0021-972X/01/$03.00/0 The Journal of Clinical Endocrinology & Metabolism Copyright © 2001 by The Endocrine Society

Vol. 86, No. 1 Printed in U.S.A.

Effects of Free Fatty Acids on Insulin Sensitivity and Hemodynamics during Mental Stress* ´ QUIER, P. BATTILANA, G. SEEMATTER, PH. SCHNEITER, E. JE

AND

L. TAPPY

Institute of Physiology, University of Lausanne School of Medicine, 1005 Lausanne, Switzerland ABSTRACT Mental stress is known to decrease systemic vascular resistance and increase muscle blood flow and to acutely enhance insulinmediated glucose disposal in healthy humans. These effects are abolished in obese patients. We therefore proposed the hypothesis that elevated free fatty acid levels may be responsible for the abnormal responses to mental stress in obesity by inhibiting endothelial cell function. To test this hypothesis, we studied a group of eight lean females during a hyperinsulinemic clamp study with and without lipid infusion. A 30-min mental stress was applied during 30 min after 150 min of hyperinsulinemia. In the study without lipid infusion, mental stress increased heart rate by 26.5%, blood pressure by 7.9%,

and cardiac index (measured with thoracic bioimpedance) by 35.9%; it decreased systemic vascular resistance by 21.9% and increased insulin-mediated glucose disposal by 18.9%. During lipid infusion, the increase in heart rate was not affected, but the increase in cardiac index, the decrease in systemic vascular resistance, and the increase in insulin-mediated glucose disposal were all inhibited. In contrast, the rise in blood pressure was increased about 2-fold (control plus 6 mm Hg vs. lipid plus 13 mm Hg, P ⬍ 0.01). These results indicate that lipid inhibits the stimulation of glucose uptake and enhances the pressor effect of mental stress, presumably by altering endothelial cell function. (J Clin Endocrinol Metab 86: 124 –128, 2001)

O

was 1.6 ⫾ 4.5 m, and body mass index was 23.4 ⫾ 2.2 kg/m2. All were in good physical condition, had no known disease, and were not currently taking any medication, with the exception of oral contraceptive agents. The experimental protocol was approved by the ethical committee of Lausanne University School of Medicine, and every participant provided informed written consent.

BESE PATIENTS have an impaired vasodilatory response to intraarterial infusion of cholinergic agonists, indicating endothelial cell dysfunction. They also have blunted stimulation of limb blood flow by hyperinsulinemia, which may contribute to produce insulin resistance (1). Mental stress normally elicits an increase in cardiac output and a drop in systemic vascular resistance that involves endothelial NO release (2– 4). These hemodynamic alterations are associated with an enhancement of the actions of insulin in healthy humans (5–7). In obese patients, both the vasodilatory effects of mental stress and the stimulation of insulinmediated glucose disposal are abrogated (8). Mental stress, however, leads to a substantial increase in blood pressure in obese patients, probably due to the predominant vasoconstrictive effects of sympathetic activation (9). Increased free fatty acids can acutely produce endothelial dysfunction in healthy humans (10). It is therefore possible that elevated free fatty acid concentrations were responsible for the alteration of the metabolic and hemodynamic responses to mental stress observed in the obese patients. To further evaluate this hypothesis we assessed the effects of a lipid infusion on the hemodynamic and metabolic effects of mental stress in healthy humans.

General procedures All experiments were performed during the follicular phase of each subject’s menstrual cycle and began in the morning after an overnight fast. The participants were instructed to consume an isocaloric diet containing 50 –55% carbohydrate and to restrain from strenuous physical activities during the 2 days preceding the studies. On the morning of each study, the subjects reported to the metabolic investigation laboratory between 0700 – 0730 h. They had been fasting since 2200 h the night before. At their arrival, subjects were weighed and measured, and they voided before being transferred to a bed where they lay quietly during the 240 min of the studies. One indwelling venous cannula was inserted into an antecubital vein of the left arm for infusion of glucose, insulin, and 6,6-2H2 glucose. Another indwelling cannula was inserted into a wrist vein of the right arm to allow serial blood samples collection. The right hand was placed in a thermostabilized box heated to 56 C to achieve partial arterialization of venous blood. Throughout the study period, indirect calorimetry was performed using a ventilated hood as previously described (11). Each subject took part, in randomized order, in two study protocols, which took place at least 1 week apart. Study 1. This experiment started between 0800 – 0830 h after subjects were prepared as described above. At 0 min, a primed (2 mg/kg BW) continuous infusion (20 ␮g/kg䡠min) of 6,6-2H2 glucose (Masstrace, Worcester, MA) was started and continued for 60 min. After 60 min, a primed continuous infusion of insulin was started at a rate of 0.4 mU/ kg䡠min, whereas glucose was clamped at 5.6 mmol/L (12) by means of an infusion of 200 g/L dextrose. During the clamp, 6,6-2H2 glucose infusion was adjusted to that of unlabeled glucose to produce a 1.25% enrichment of exogenous glucose. At 210 min, a 30-min mental stress, consisting of 5-min periods of mental arithmetics alternated (6) with 5-min periods of Stroop’s color word conflict test, was applied (13). Indirect calorimetry was continuously performed, and the hyperinsulinemic euglycemic clamp was continued until 240 min. Blood samples were collected at 30-min intervals throughout the study and at 5, 10, 20, and 30 min after the beginning of the mental stress. Blood pressure was recorded every 30 min (using a Sentry HSD 400; Automated Screening

Subjects and Methods Subjects Eight healthy female subjects were selected to participate in this study. Their mean age was 22.9 ⫾ 2.5 yr, weight was 56.9 ⫾ 2.5 kg, height Received June 21, 2000. Revision received August 30, 2000. Accepted September 11, 2000. Address all correspondence and requests for reprints to: Dr. L. Tappy, Institut de Physiologie, 7 rue du Bugnon, 1005 Lausanne, Switzerland. E-mail: [email protected]. * This work was supported by a grant from the Swiss National Science Foundation (32– 45387-95).

124

EFFECTS OF LIPIDS DURING MENTAL STRESS

125

Devices, Costa Mesa, CA) and for the mental stress every 5 min. Cardiac output was measured with thoracic bioimpedance (14) using a Bomed impedancemeter (Bomed NCCOM3-R7 CDDP system, Bomed Medical Manufacturing Ltd., Irvine, CA). Cardiac index was calculated as cardiac output/body surface area. Systemic vascular resistance was calculated as mean arterial pressure divided by cardiac output. Study 2. This study was identical to study 1, except that an infusion of a 20% soybean lipid emulsion (20% Lipovenos, Fresenius, Stans, Switzerland) was infused at a rate of 1 mL/min from 0 –210 min.

Analytical measurements The plasma glucose concentration was measured enzymatically using a glucose analyzer II (Beckman Coulter, Inc., Fullerton, CA). Commercial RIA kits were used for determination of plasma insulin (Biochem Immunosystems GmbH, Freiburg, Germany) and glucagon (Linco Research, Inc., St. Charles, MO) concentrations. Plasma norepinephrine concentrations were determined by high pressure liquid chromatography with electrochemical detection (15). Plasma 6,6-2H2 glucose enrichments were determined by gas chromatography-mass spectrometry, as previously described (16). Plasma free fatty acid concentrations were measured by means of a calorimetric method, using a kit from Wako (Freiburg, Germany).

Calculations The glucose rates of appearance and disappearance were calculated from 6,6-2H2 glucose dilution using the “hot” glucose infusion equations (17). Energy expenditure and net substrate oxidation rates were calculated from respiratory gas exchanges using the equations of Livesey and Elia (18). For this purpose, the urinary nitrogen excretion rate was calculated from urinary urea concentrations.

Statistics All results are expressed as the mean ⫾ 1 sem unless stated otherwise. In each study protocol, the evolution of all parameters collected over time was assessed with repeated measures ANOVA. Comparison between studies 1 and 2 was performed by two-way ANOVA and paired t tests with Bonferonni’s adjustment.

FIG. 1. Plasma glucose, insulin, and free fatty acid concentrations during hyperinsulinemic clamp studies and mental stress without (control, F) and with infusion of a lipid emulsion (lipids, E). *, P ⬍ 0.05 or less vs. control.

Results

Plasma glucose, insulin, and glucagon concentrations did not differ between the two studies throughout the 240-min experimental protocol (Fig. 1). Plasma free fatty acid concentrations were suppressed to 82% of their basal concentrations in study 1 and remained elevated at an average value of 0.549 mmol/L in study 2 as a consequence of lipid infusion (Fig. 1). After 2 h of hyperinsulinemia, lipid infusion in study 2 resulted in a 16.5% reduction in the glucose rate of disappearance and a 24% reduction in net glucose oxidation compared with those in study 1 (Fig. 2). There was, however, no difference in energy expenditure (Fig. 3) or in endogenous glucose production (3.0 ⫾ 0.9 ␮mol/kg䡠min in study 1 vs. 4.9 ⫾ 0.8 ␮mol/kg䡠min in study 2; Fig. 2). Hemodynamic parameters (Fig. 4) were also comparable in both studies during this period. In study 1, mental stress increased norepinephrine concentrations (from 0.73 ⫾ 0.04 to 0.85 ⫾ 0.05 nmol/L; P ⬍ 0.05) and epinephrine concentrations (from 344 ⫾ 29 to 453 ⫾ 54 pmol/L; P ⬍ 0.05), blood pressure by 7.9% (P ⫽ 0.0006), cardiac index by 35.9%, and heart rate by 26.5%; it decreased systemic vascular resistance by 21.9% (Fig. 4). It also stimulated energy expenditure, which increased by 15.8% (Fig. 3), and enhanced the glucose rate of disappearance by 18.9%

(Fig. 2). There was no effect on endogenous glucose production, which remained at 4.5 ⫾ 1.0 ␮mol/kg䡠min (Fig. 2). In study 2, lipid infusion did not alter the increases in plasma norepinephrine (from 0.63 ⫾ 0.04 to 0.94 ⫾ 0.07 nmol/L; P ⬍ 0.05), plasma epinephrine (from 371 ⫾ 41 to 448 ⫾ 33 pmol/L; P ⬍ 0.05), in heart rate (Fig. 4), and energy expenditure induced by mental stress (Fig. 3). However, it totally prevented the increase in cardiac output and the decrease in systemic vascular resistance (Fig. 4) as well as the stimulation of glucose rate of disappearance (Fig. 2). Instead, it markedly enhanced the rise in blood pressure, which amounted to 13 mm Hg, on the average (P ⫽ 0.0005; Fig. 4). This increase in blood pressure was 116.7% higher than that in study 1 (P ⬍ 0.01). Discussion

The results obtained indicate that infusion of lipids not only decreased insulin-mediated glucose utilization, but also severely inhibited some hemodynamic and metabolic effects of mental stress. Furthermore, it reproduced in healthy lean females most of the abnormal responses observed in obese patients (8). Lipid infusion prevented the drop in systemic vascular

126

BATTILANA ET AL.

JCE & M • 2001 Vol. 86 • No. 1

FIG. 2. Plasma 6,6-2H2 glucose enrichment and glucose kinetics during hyperinsulinemic clamp studies and mental stress with and without lipid infusion. Symbols are explained in Fig. 1.

FIG. 3. Energy expenditure and net substrate oxidation rates during hyperinsulinemic clamp studies and mental stress without or with lipid infusion. Symbols are explained in Fig. 1.

resistance and the increase in cardiac output normally elicited by mental stress. In contrast, it did not affect the stimulation of catecholamine release or the increase in heart rate,

indicating that lipids did not interfere with sympathoadrenal stimulation during mental stress. Instead, these observations are consistent with a lipid-induced alteration of endothelial cell function, leading to inadequate NO release during mental stress. In support of this explanation, it has been demonstrated that the skeletal muscle vasodilation induced by mental stress could be inhibited by NO synthase inhibitors (2, 4), and that lipid infusion impaired the vasodilatory effects of intraarterial cholinergic agents, which require endothelial NO release (10). As a consequence of an unaltered sympathetic stimulation but impaired vasodilation, mental stress produced a substantial increase in arterial pressure. A modest increase in cardiac output produced by the chronotropic effect of mental stress together with an increase in vascular resistance secondary to the predominant effect of sympathetic activation of ␣1-vascular receptor are likely to explain this rise in blood pressure. Mental stress is known to acutely increase insulin-mediated glucose disposal (5– 8). Although mental stress tended to transiently increase endogenous glucose production in experiments performed without lipids only, this effect was of slight magnitude and did not reach statistical significance. This observation is consistent with our previous report that stimulation of the sympathoadrenal nervous system elicited by mental stress fails to overcome insulin-induced inhibition of endogenous glucose production. Stimulation of insulinmediated glucose disposal was also abolished by lipids. In contrast, the increase in energy expenditure was not altered, indicating that sympathetic activation of metabolically active tissues (19) was not impaired. We have proposed the hypothesis that the mechanism by which mental stress increases insulin sensitivity is through an increased blood flow to insulin tissue (8). There is indeed evidence that increased muscle blood flow may enhance insulin actions by increasing

EFFECTS OF LIPIDS DURING MENTAL STRESS

127

FIG. 4. Hemodynamic parameters during hyperinsulinemic clamp studies and mental stress without or with lipid infusion. Symbols are explained in Fig. 1.

the amount of both glucose and insulin reaching insulinsensitive tissues (reviewed in Ref. 20). Although we did not directly measure muscle blood flow in this study, our observation that lipids simultaneously prevents both the drop in systemic vascular resistance and the enhancement of insulin action during mental stress is entirely consistent with this hypothesis. We previously observed that administration of ␤-adrenergic antagonists produce effects similar to those of lipids during mental stress (8). Infusion of propranolol also inhibited the decrease in systemic vascular resistance and the increase in insulin-mediated glucose disposal during mental stress. Although still consistent with the hypothesis that vasodilation is operative in enhancing insulin actions, this observation suggests that the hemodynamic effects of mental stress may involve simultaneous ␤-adrenergic and NO-ergic vasodilation and ␣1-adrenergic vasoconstriction. We also reported that obese nondiabetic patients have a blunted decrease in systemic vascular resistance, an accentuated rise in blood pressure, as well as an absence of stimulation of insulin actions during mental stress (8). All of these alterations were reproduced in healthy lean females by lipid infusion, suggesting that increased fatty acid concentrations may be responsible for the alterations observed in obese patients. This hypothesis is consistent with the observation of Steinberg et al. that free fatty acids produce endothelial dysfunction in healthy human subjects (1). The endothelial dysfunction induced by lipids may have several important consequences. First, it may participate in the insulin resistance observed in obesity, in part by preventing regulatory increases in blood flow to insulin-sensitive tissues. Secondly, it may contribute to a rise in blood pressure observed in patients submitted to stressful conditions (21). Our present observations therefore suggest that fatty acid-induced en-

dothelial dysfunction may be of importance in both the metabolic and cardiovascular complications of obesity. References 1. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. 1996 Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest. 97:2601–2610. 2. Dietz NM, Rivera JM, Eggener SE, Fix RT, Warner DO, Joyner MJ. 1994 Nitric oxide contributes to the rise in forearm blood flow during mental stress in humans. J Physiol. 480:361–368. 3. Joyner MJ, Dietz NM. 1997 Nitric oxide and vasodilation in human limbs. J Appl Physiol. 83:1785–1796. 4. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO, 3rd, Panza JA. 1997 Role of nitric oxide in the vasodilator response to mental stress in normal subjects. Am J Cardiol. 80:1070 –1074. 5. Jern S. 1994 Effects of insulin on vascular responses to mental stress and norepinephrine in human forearm. Hypertension. 24:686 – 694. 6. Moan A, Hoieggen A, Nordby G, Os I, Eide I, Kjeldsen SE. 1995 Mental stress increases glucose uptake during hyperinsulinemia: associations with sympathetic and cardiovascular responsiveness. Metabolism Clin Exp. 44:1303–1307. 7. Touma T, Takishita S, Kimura Y, Muratani H, Fukiyama K. 1996 Mild mental stress increases insulin sensitivity in healthy young men. Clin Exp Hypertension. 18:1105–1114. 8. Seematter G, Guenat E, Schneiter P, Cayeux C, Je´quier E, Tappy L. Effects of mental stress on insulin-mediated glucose metabolism and energy expenditure in lean and obese women. Am J Physiol. 279:E799 –E805. 9. Sung BH, Wilson MF, Izzo Jr JL, Ramirez L, Dandona P. 1997 Moderately obese, insulin-resistant women exhibit abnormal vascular reactivity to stress. Hypertension. 30:848 – 853. 10. Steinberg HO, Baron A. 1997 Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest. 100:1230 –1239. 11. Jallut D, Golay A, Munger R, et al. 1990 Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism. Metabolism. 39:1068 –1075. 12. DeFronzo RA, Soman V, Sherwin RS, Hendler R, Felig P. 1978 Insulin binding to monocytes and insulin action in human obesity, starvation and refeeding. J Clin Invest. 62:204 –213. 13. Freyschuss U, Hjemdahl P, Juhlin-Dannfelt A, Linde B. 1988 Cardiovascular and sympathoadrenal responses to mental stress: influence of ␤-blockade. Am J Physiol. 255:H1443–H1451. 14. Sramek BB. 1994 Thoracic electrical bioimpedance measurement of cardiac output. Crit Care Med. 22:1337–1339.

128

BATTILANA ET AL.

15. Hallman J, Farnebo LO, Hamberger B, Jonsson G. 1978 A sensitive method for determination of plasma catecholamines using liquid chromatography with electrochemical detection. Life Sci. 23:1049 –1052. 16. Tappy L, Dussoix P, Iynedjian P, et al. 1997 Abnormal regulation of hepatic glucose output in maturity onset diabetes of the young caused by a specific mutation of the glucokinase gene. Diabetes. 46:204 –208. 17. Finegood DT, Bergman RN, Vranic M. 1987 Estimation of endogenous glucose production during hyperinsulinemic euglycemic glucose clamps: comparison of labelled and unlabelled glucose infusates. Diabetes. 36:914 –924. 18. Livesey G, Elia M. 1988 Estimation of energy expenditure, net carbohydrate utilization, and net fat oxidation and synthesis by indirect calorimetry; eval-

JCE & M • 2001 Vol. 86 • No. 1

uation of errors with special reference to the detailed composition of foods. Am J Clin Nutr. 47:608 – 628. 19. Blaak EE, Van Baak MA, Kemerink GJ, Pakbiers MT, Heidendal GA, Saris WH. 1994 ␤-Adrenergic stimulation of skeletal muscle metabolism in relation to weight reduction in obese men. Am J Physiol. 267:E316 –E322. 20. Baron AD. 1993 Cardiovascular actions of insulin in humans. Implications for insulin sensitivity and vascular tone. Bailliere Clin Endocrinol Metab. 7:961–987. 21. Steptoe A, Cropley M, Griffith J, Joekes K. 1999 The influence of abdominal obesity and chronic work stress on ambulatory blood pressure in men and women. Int J Obes. 23:1184 –1191.